Detail

Study ID: COG ACNS1721

Title:

A Phase 2 Study of Veliparib (ABT-888, IND # 139199) and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients with Newly Diagnosed High-Grade Glioma (HGG) without H3 K27M or BRAFV600E Mutations

Location:
Fargo Region, Sioux Falls Region
Principal Investigator:
Kayelyn Wagner, MD,Samuel Milanovich, MD
Disease:
CNS (Brain Tumors)
Stage:
Phase II
Status:
Active - Open to Accrual